• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Coloplast Launches New Catheter in the U.S.

    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors

    NAMSA Relaunches Medtech Outsourcing Solution

    Rollomatic Inc. Welcomes Joe Kane as CEO

    Alveo Technologies Announces New Executive Leadership
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Medbio LLC

    NDH Medical Inc.

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Medbio LLC

    NDH Medical Inc.

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Bovie Medical Corporation Appoints CEO

    New leader brings to the position nearly 25 years of experience in the medical technology industry.

    Related CONTENT
    • Single Blood Test Screens for Eight Cancer Types
    • IP Veteran Joins BioSig Technologies’ Board of Directors
    • Study Confirms Efficacy of Latera Absorbable Nasal Implant
    • CRO Industry Veteran Joins SynteractHCR Board of Directors
    • AtriCure Founder Joins Genetesis Board of Directors
    Business Wire01.19.18
    Bovie Medical Corporation, a maker of medical devices and supplies and the developer of J-Plasma, a patented new surgical product, has named Charles D. Goodwin as CEO, and has joined the company’s Board of Directors. Goodwin succeeds Robert L. Gershon, who has resigned to pursue other opportunities.
     
    “After thorough consideration, the Board of Directors has voted unanimously to appoint Charlie to the role of chief executive officer,” said Andrew Makrides, board chairman. “The appointment of Mr. Goodwin represents an important strategic decision for Bovie Medical as we pursue strong growth performance and improving profitability. Charlie is the ideal executive to lead the company on its next stage of growth. The Board is confident that he will drive growth and enhance the company’s operational performance, which together we believe will increase shareholder value going forward.”

    Over the course of his nearly 25-year career in the medical device industry, Goodwin has a demonstrated track record of delivering strong revenue growth and operational excellence. As vice president of Olympus Corporation’s global surgical energy group for five years, he was directly responsible for the group’s global commercial strategy, managing a team of over 500 employees with full profit and loss responsibility. Prior to joining Olympus, Goodwin was president of worldwide sales at Gyrus ACMI, where he led the business to record growth in sales and profit, and served as a key member of the executive team that negotiated the acquisition of Gyrus ACMI by Olympus for $2.2 billion. Before his promotion to president of worldwide sales, Goodwin was instrumental in developing Gyrus’s global distribution network as president, Surgical Division, where he achieved average annual sales growth of 35 percent for three consecutive years.
     
    “I am excited to lead Bovie Medical as the Company commercializes its transformational J-Plasma technology and continues to grow sales,” said Goodwin. “J-Plasma represents an exciting step forward from the surgical energy technologies that have been traditionally applied in these markets, with its potential in several surgical specialties to improve surgical precision and enhance procedure safety by minimizing collateral tissue damage. I am looking forward to working together with our employees and the board to continue to drive the commercial adoption of this energy technology for the benefit of our customers and shareholders.”
     
    The company now expects total 2017 revenue in the range of $37 million to $37.5 million, representing flat sales to 1 percent growth year-over-year, compared to prior guidance which assumed growth in the range of approximately 4 percent to 5 percent year-over-year. The change in the total revenue guidance range is driven primarily by softer sales performance in Bovie Medical's Core segment in the fourth quarter; J-Plasma sales growth expectations remain unchanged from prior guidance expectations.
     
    The Company expects total revenue growth to be driven by:
    • Advanced Energy sales growth in the range of approximately 93 percent to 98 percent year-over-year, unchanged from prior guidance expectations;
    • An OEM sales decline in the range of approximately 53 percent to 54 perent year-over-year, as compared to a decline in the range of approximately 50 percent to 55 percent previously;
    • Core sales growth in the range of up to 1 percent year-over-year, as compared to growth in the range of approximately 3 percent to 4 percent year-over-year previously.

    The Company now expects a GAAP net loss of approximately $6.3 million, compared to prior guidance for a loss of $5 million and adjusted EBITDA loss in a range of $4.6 million to $4.8 million, compared to adjusted EBITDA loss in a range of $3.3 to $3.5 million previously. The new GAAP net loss and adjusted EBITDA loss range for fiscal year 2017 includes approximately $900,000  in separation expense related to the CEO change.
     
    Bovie Medical Corporation is a maker of medical devices and supplies as well as the developer of J-Plasma, a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. The new J-Plasma handpieces with Cool-Coag technology deliver the precision of helium plasma energy, the power of traditional monopolar coagulation and the efficiency of plasma beam coagulation—enabling thin-layer ablation and dissection and fast coagulation with a single instrument, minimizing instrument exchange and allowing a surgeon to focus on their patient and their procedures. With Cool-Coag technology, the new J-Plasma handpieces can deliver three distinctly different energy modalities, further increasing the utility and versatility of the J-Plasma system. Bovie Medical Corporation also manufactures a range of electrosurgical products and technologies marketed through both private labels and the company’s own brands (Bovie, IDS, and DERM) to distributors worldwide. The company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.
    Related Searches
    • vice president
    • Manufacturing
    • j-plasma
    • medical technology
    Suggested For You
    Single Blood Test Screens for Eight Cancer Types Single Blood Test Screens for Eight Cancer Types
    IP Veteran Joins BioSig Technologies’ Board of Directors IP Veteran Joins BioSig Technologies’ Board of Directors
    Study Confirms Efficacy of Latera Absorbable Nasal Implant Study Confirms Efficacy of Latera Absorbable Nasal Implant
     CRO Industry Veteran Joins SynteractHCR Board of Directors CRO Industry Veteran Joins SynteractHCR Board of Directors
    AtriCure Founder Joins Genetesis Board of Directors AtriCure Founder Joins Genetesis Board of Directors
    BioSig Technologies Hires Chief Commercialization Officer BioSig Technologies Hires Chief Commercialization Officer
    Deep Brain Stimulation May Address Chronic Depression in Some Patients Deep Brain Stimulation May Address Chronic Depression in Some Patients
    Compensation Conundrum: MPO Compensation Conundrum: MPO's Industry Salary Survey
     BIOLASE Names Board Chairman  BIOLASE Names Board Chairman
    Healthcare and Medical Technology Executive Joins Invuity’s Board of Directors Healthcare and Medical Technology Executive Joins Invuity’s Board of Directors
    Publicis Health CEO Joins electroCore’s Board of Directors Publicis Health CEO Joins electroCore’s Board of Directors
    Invacare Corporation Appoints Corporate Finance Expert to its Board Invacare Corporation Appoints Corporate Finance Expert to its Board
    Insulet Corporation Adds Two to Board of Directors Insulet Corporation Adds Two to Board of Directors
    3. GE Healthcare 3. GE Healthcare
    4. Siemens Healthineers 4. Siemens Healthineers

    Related Breaking News

    • Diagnostics
      Single Blood Test Screens for Eight Cancer Types

      Single Blood Test Screens for Eight Cancer Types

      Provides unique new framework for early detection of the most common cancers.
      Johns Hopkins Medicine 01.18.18

    • IP Veteran Joins BioSig Technologies’ Board of Directors

      IP Veteran Joins BioSig Technologies’ Board of Directors

      New member replaces former Celgene Global Health CEO and Celgene Corporation chief medical officer.
      BioSig Technologies Inc. 12.11.17

    • Study Confirms Efficacy of Latera Absorbable Nasal Implant

      Study Confirms Efficacy of Latera Absorbable Nasal Implant

      Eighteen and 24-month results reinforce clinical benefits without cosmetic downside.
      Globe Newswire 11.10.17


    •  CRO Industry Veteran Joins SynteractHCR Board of Directors

      CRO Industry Veteran Joins SynteractHCR Board of Directors

      New board member has spent 25 years in clinical development arena.
      Business Wire 11.08.17

    • Cardiovascular
      AtriCure Founder Joins Genetesis Board of Directors

      AtriCure Founder Joins Genetesis Board of Directors

      Veteran medical device entrepreneur adds experience, connections to cardiac imaging startup.
      Business Wire 10.31.17

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    Breaking News
    • Coloplast Launches New Catheter in the U.S.
    • Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    • NAMSA Relaunches Medtech Outsourcing Solution
    • Rollomatic Inc. Welcomes Joe Kane as CEO
    • Alveo Technologies Announces New Executive Leadership
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Dr. Ranjini Murthy Joins Azelis Americas as SVP of Commercial and Digital Excellence
    Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
    Berry Health Benefits Symposium Includes Panel on Dietary Supplements
    Coatings World

    Latest Breaking News From Coatings World

    Evonik, Partners Launch PlasCO₂ Project for C4 Chemicals Production
    Masco Corporation Reaches $5 Million Milestone in Grant Program
    Arkema Partners with Research Institute to Open New Lab in France
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Coloplast Launches New Catheter in the U.S.
    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    NAMSA Relaunches Medtech Outsourcing Solution
    Contract Pharma

    Latest Breaking News From Contract Pharma

    iuvo BioScience Appoints Industry Exec to Lead Lab Biz
    Seqens Opens Flagship R&D Center in Greater Boston
    Azelis Americas Appoints Ranjini Murthy Commercial, Digital Excellence SVP
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    U.S. Prestige Beauty Industry Sales Revenue Grew 15% in 2022
    Personal Care Market Forecasted to Grow at CAGR of 6.4% from 2022-2027
    P&G Designs Recyclable Pump Dispenser
    Happi

    Latest Breaking News From Happi

    Nutricosmetics & Wellness Market Expected to Grow 5% by 2033
    Anastasia Beverly Hills Celebrates 25th Anniversary
    Henkel Honors Leading Suppliers During American Cleaning Institute Convention Week
    Ink World

    Latest Breaking News From Ink World

    Early-Bird Registration Opens for Print UV 2023
    Arkema Partners with Research Institute to Open Lab in France
    White Inorganic Pigments Market Worth $29.5 Billion by 2026: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    AWA to host 23rd Global Release Liner Industry Conference & Exhibition
    Color-Logic certifies Ecofoil digital labestock for cut sheet printers
    Brandywine Label Printing names Dave Rosen new president
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ahlstrom Launches New Generation FluoroFree Technology
    Berry to Begin Production at India Healthcare Hub Early This Year
    FiltXPO to be Held in October
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    ODT's Most-Read Stories This Week—Jan. 28
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Textiles are Smarter with Durak SilverPro Conductive Threads
    Arkema Partners with Research Institute to Open Lab in Mulhouse, France
    Veridos to Become Majority Shareholder in NetSeT

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login